Insider trades

Kanya Rajangam, Chief Officer of Senti Biosciences Holdings SNTI, has filed 0 purchases and 2 sales on the open market. The latest trade was on 03/09.

Kanya Rajangam

Pres. & Chief Med. & Dev. Off
First filing
23/02/02
Trades
15 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
03/09

Trading activity

Transactions

Trade type
SNTI
Open-market sale25/02/04–25/02/0625/02/061,479 sh2 trades$4.11avg.$6,074.13−14.6%